BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9920367)

  • 21. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
    Wartofsky L
    Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory diagnosis before onset and prediction of Graves' disease].
    Hidaka Y; Tada H; Amino N
    Rinsho Byori; 1997 Sep; 45(9):825-30. PubMed ID: 9311254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD antigen (cytokine) expression in various hyperthyroid states and use in the assessment of propylthiouracil treatment.
    Murphy ED; Kallio P
    J Lab Clin Med; 1994 Aug; 124(2):255-62. PubMed ID: 8051490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postpartum thyroiditis and Basedow disease].
    Agard C; Chaillous L; Murat A; Tranchant D; Charbonnel B
    Presse Med; 1997 Jul; 26(23):1095-7. PubMed ID: 9246101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
    Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
    Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The deceptively tender goiter.
    Temple TE; Wilhoit GB; Williams RB; Mitchell GS; Satchwell S; Harrington WG; Spence SN
    J Fam Pract; 1981 Jan; 12(1):127-32. PubMed ID: 6893840
    [No Abstract]   [Full Text] [Related]  

  • 31. Thyroid dysfunction following pregnancy and implications for breastfeeding.
    Amino N; Arata N
    Best Pract Res Clin Endocrinol Metab; 2020 Jul; 34(4):101438. PubMed ID: 32651061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preliminary clinical observation and analysis of childbearingage women with a history of iodine-131 treatment for Graves' disease.
    Guan L; Chen G; Zhang J; Wang L
    Biosci Trends; 2016 Sep; 10(4):307-14. PubMed ID: 27181740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis.
    Kubota S; Amino N; Matsumoto Y; Ikeda N; Morita S; Kudo T; Ohye H; Nishihara E; Ito M; Fukata S; Miyauchi A
    Thyroid; 2008 Mar; 18(3):283-7. PubMed ID: 18001177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A long-term follow-up of postpartum thyroiditis.
    Othman S; Phillips DI; Parkes AB; Richards CJ; Harris B; Fung H; Darke C; John R; Hall R; Lazarus JH
    Clin Endocrinol (Oxf); 1990 May; 32(5):559-64. PubMed ID: 2364561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect on exophthalmos of various methods of treatment of Graves' disease.
    Gwinup G; Elias AN; Ascher MS
    JAMA; 1982 Apr; 247(15):2135-8. PubMed ID: 6895919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroxine excess and pregnancy.
    Lazarus JH
    Acta Med Austriaca; 1994; 21(2):53-6. PubMed ID: 7527990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
    N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reversible hyperthyroidism caused by painless postpartum thyroiditis].
    Heim J
    Sem Hop; 1983 May; 59(20):1553-5. PubMed ID: 6308780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemiagenesis of the thyroid gland.
    Burman KD; Adler RA; Wartofsky L
    Am J Med; 1975 Jan; 58(1):143-6. PubMed ID: 1172918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease.
    Tuttle RM; Patience T; Budd S
    Thyroid; 1995 Aug; 5(4):243-7. PubMed ID: 7488862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.